Curbstone Financial Management Corp’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,266
| Closed | -$483K | – | 206 |
|
|
2025
Q1 | $483K | Buy |
4,266
+140
| +3% | +$15K | 0.1% | 166 |
|
|
2024
Q4 | $436K | Sell |
4,126
-100
| -2% | -$10.7K | 0.09% | 177 |
|
|
2024
Q3 | $456K | Hold |
4,226
| – | – | 0.1% | 179 |
|
|
2024
Q2 | $459K | Hold |
4,226
| – | – | 0.1% | 173 |
|
|
2024
Q1 | $558K | Hold |
4,226
| – | – | 0.12% | 158 |
|
|
2023
Q4 | $514K | Buy |
4,226
+30
| +0.7% | +$3.35K | 0.12% | 161 |
|
|
2023
Q3 | $471K | Buy |
4,196
+120
| +3% | +$15.2K | 0.12% | 159 |
|
|
2023
Q2 | $593K | Hold |
4,076
| – | – | 0.14% | 141 |
|
|
2023
Q1 | $527K | Sell |
4,076
-50
| -1% | -$6.28K | 0.13% | 150 |
|
|
2022
Q4 | $526K | Sell |
4,126
-40
| -1% | -$4.64K | 0.13% | 153 |
|
|
2022
Q3 | $436K | Buy |
4,166
+48
| +1% | +$5.27K | 0.11% | 167 |
|
|
2022
Q2 | $433K | Sell |
4,118
-1,500
| -27% | -$178K | 0.1% | 170 |
|
|
2022
Q1 | $719K | Sell |
5,618
-169
| -3% | -$20.4K | 0.13% | 149 |
|
|
2021
Q4 | $714K | Hold |
5,787
| – | – | 0.13% | 154 |
|
|
2021
Q3 | $822K | Buy |
5,787
+206
| +4% | +$30.3K | 0.16% | 133 |
|
|
2021
Q2 | $871K | Hold |
5,581
| – | – | 0.16% | 124 |
|
|
2021
Q1 | $867K | Hold |
5,581
| – | – | 0.17% | 119 |
|
|
2020
Q4 | $835K | Buy |
5,581
+145
| +3% | +$20.5K | 0.17% | 120 |
|
|
2020
Q3 | $719K | Buy |
5,436
+43
| +0.8% | +$5.62K | 0.17% | 125 |
|
|
2020
Q2 | $625K | Hold |
5,393
| – | – | 0.16% | 129 |
|
|
2020
Q1 | $529K | Sell |
5,393
-206
| -4% | -$27K | 0.16% | 136 |
|
|
2019
Q4 | $814K | Hold |
5,599
| – | – | 0.19% | 125 |
|
|
2019
Q3 | $746K | Hold |
5,599
| – | – | 0.19% | 127 |
|
|
2019
Q2 | $640K | Buy |
5,599
+51
| +0.9% | +$5.97K | 0.17% | 140 |
|
|
2019
Q1 | $688K | Sell |
5,548
-51
| -0.9% | -$5.8K | 0.19% | 134 |
|
|
2018
Q4 | $564K | Buy |
5,599
+515
| +10% | +$57.9K | 0.17% | 137 |
|
|
2018
Q3 | $649K | Buy |
5,084
+154
| +3% | +$18.3K | 0.17% | 138 |
|
|
2018
Q2 | $533K | Hold |
4,930
| – | – | 0.15% | 147 |
|
|
2018
Q1 | $522K | Buy |
4,930
+2,517
| +104% | +$292K | 0.15% | 146 |
|
|
2017
Q4 | $283K | Sell |
2,413
-2,414
| -50% | -$273K | 0.16% | 141 |
|
|
2017
Q3 | $549K | Buy |
4,827
+2,991
| +163% | +$345K | 0.16% | 142 |
|
|
2017
Q2 | $229K | Hold |
1,836
| – | – | 0.14% | 153 |
|
|
2017
Q1 | $218K | Buy |
+1,836
| New | +$208K | 0.13% | 160 |
|
|
2015
Q3 | – | Sell |
-2,006
| Closed | -$213K | – | 167 |
|
|
2015
Q2 | $213K | Sell |
2,006
-62
| -3% | -$6.86K | 0.14% | 154 |
|
|
2015
Q1 | $236K | Hold |
2,068
| – | – | 0.16% | 142 |
|
|
2014
Q4 | $228K | Buy |
+2,068
| New | +$218K | 0.18% | 128 |
|
Other funds holding ZBH
Curbstone Financial Management Corp's ZBH Position: Q2 2025 in Review
Curbstone Financial Management Corp sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 4,266 shares — an estimated $483K sold.
Curbstone Financial Management Corp first reported a position in ZBH in Q4 2014 and held it in 36 quarters. The position peaked at $871K in Q2 2021. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.
- Curbstone Financial Management Corp reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
- Curbstone Financial Management Corp sold 4,266 Zimmer Biomet shares in Q2 2025, an estimated $483K.
- Curbstone Financial Management Corp first reported a position in Zimmer Biomet in Q4 2014 and held it in 36 quarters.
- Curbstone Financial Management Corp's Zimmer Biomet position peaked at $871K in Q2 2021.
- 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.
Based on Curbstone Financial Management Corp's 13F filing for Q2 2025, filed 29 Jul 2025.